Leveraging cfDNA Methylation Status to Predict Response to Therapy & Exploring its Potential for Early Cancer Detection
Time: 11:30 am
day: Day Two Track A (AM)
Details:
- Leveraging cfDNA Methylation Status to Predict Response to Therapy & Exploring its Potential for Early Cancer Detection
- cfDNA methylation status: prioritizes of the field and future landscape
- Case study: use of whole blood methylation status for response to therapy in multiple myeloma
- Use of cfDNA methylation status for cancer-risk prediction in solid tumors
